Skip to main content
. Author manuscript; available in PMC: 2021 Jul 26.
Published in final edited form as: World J Surg. 2020 Sep 15;45(1):109–115. doi: 10.1007/s00268-020-05772-z

Table 1.

Comparing baseline characteristics of patients who did and did not proceed to surgery. All data collected at time of initial POSH consult appointment. Student’s t test used to compare continuous variables (age, number of medications, and ACB score). Chi-squared test or Fischer’s exact test used to compare dichotomous variables.

Surgery N = 416 No surgery N = 33 P
Age (Mean, SD) 76.2 (7.1) 79.1 (7.7) 0.02*
Males 195 (46.9) 18 (54.5) 0.40
Some college (or higher) level of education 240 (57.7) 20 (60.6) 0.74
Smoker: current or prior 219 (52.6) 21 (63.6) 0.22
Alcohol use (any amount) 154 (37.0) 13 (39.4) 0.79
BMI 0.57
 <18.5 10 (2.4) 2 (6.1)
 18.5–24.9 139 (33.4) 13 (39.4)
 25.0–29.9 140 (33.7) 11 (33.3)
 >30 126 (30.3) 7 (21.2)
Total # medications (Mean, SD) 11.4 (6.2) 13.5 (6.7) 0.05
Anticholinergic Burden Score (Mean, SD) 1.3 (2.1) 1.8 (2.1) 0.20
Benzodiazepine use 72 (17.3) 5 (15.2) 0.75
Deficiency in 1 + ADL 66 (15.9) 10 (30.3) 0.03*
Deficiency in 1 + iADL 198 (47.6) 21 (63.6) 0.08
Cognitive impairment present 231 (55.5) 24 (72.7 0.06
Referring surgical service 0.01*
 Neurosurgery 100 (24.0) 5 (15.2)
 Orthopedics 1 (0) 0 (0)
 Colorectal 139 (33.4) 9 (27.3)
 Hepatopancreaticobiliary 18 (4.3) 2 (6.1)
 General 124 (29.8) 8 (24.2)
 Vascular 5 (1.2) 1 (3.0)
 Cardiac 3 (0.7) 2 (6.1)
 Urology 20 (4.8) 5 (12.2)
 Oncology 3 (0.7) 0 (0)
 Endocrine 3 (0.7) 0 (0)
 Combined 0 (0) 1 (3.0)
Sensory impairment 0.64
 Hearing impairment 12 (36.4) 150 (36.1)
 Vision impairment 19 (57.6) 285 (68.5)
Comorbidities 0.02*
Depression 12 (36.4) 121 (29.1)
Anxiety 9 (27.3) 102 (24.5)
Diabetes 9 (27.3) 111 (26.7)
Hypertension 26 (78.8) 294 (70.7)
CAD 12 (36.4) 108 (26.0)
CHF 10 (30.3) 50 (12.0)
Afib 8 (24.2) 61 (14.7)
H/o VTE 2 (6.1) 44 (10.6)
COPD 6 (18.2) 49 (11.8)
Asthma 2 (6.1) 35 (8.4)
OSA 1 (3.0) 56 (13.5)
Parkinson’s disease 3 (9.1) 6 (1.4)
History of CVA 5 (15.2) 61 (14.7)
*

P value ≤ 0.05 considered significant and is denoted